The U.S. Department of Health and Human Services (HHS) recently released an additional $487 million to supplement first-year funding through its State Opioid Response (SOR) grant program. The awards are part of HHS’s five-point opioid strategy and the Trump administration’s efforts to combat the opioid crisis.
Combined with other awards to be provided under the program later this year, the total amount of SOR grants to states and territories this year will total more than $1.4 billion. The funding will expand access to effective opioid addiction treatment, particularly to medication-assisted treatment (MAT) with appropriate social supports. The SOR grants administered by HHS’s Substance Abuse and Mental Health Services Administration (SAMHSA) aims to address the opioid crisis by increasing access to MAT using the three Food and Drug Administration (FDA) approved medications for the treatment of opioid use disorder, reducing unmet treatment need, and reducing the number of opioid overdose-related deaths.
It is the mission of the U.S. Department of Health & Human Services (HHS) to enhance and protect the health and well-being of all Americans. HHS fulfills the mission by providing for effective health and human services, and by fostering advances in medicine, public health, and social services.
This was reported by HHS on March 20, 2019.
Contact Information: The U.S. Department of Health & Human Services, 200 Independence Avenue Southwest, Washington DC 20201; (877) 696-6775; Website: www.hhs.gov